Verapamil Hydrochloride Tablet, Extended Release
Product Images NDC 71209-104

5 FDA label images from Cadila Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 71209-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Verapamil-structure (Verapamil Structure)

Verapamil-structure (Verapamil Structure)
Chemical structure of verapamil hydrochloride showing its molecular arrangement including aromatic rings, methoxy groups, and the hydrochloride part. Molecular formula C27H38N2O4·HCl and molecular weight 491.08 are displayed.*
FDA Label Image

Verapamil-tab-180mg-container-label-100count.jpg (Verapamil Tab 180mg Container Label 100count)

Verapamil-tab-180mg-container-label-100count.jpg (Verapamil Tab 180mg Container Label 100count)
Label for Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg strength. The label indicates 100 tablets in the package, manufactured by Cadila Pharmaceuticals Limited, with storage instructions and prescription-only status. The design includes dosage identification and controlled room temperature storage guidance.*
FDA Label Image

Verapamil-tab-180mg-container-label-500count.jpg (Verapamil Tab 180mg Container Label 500count)

Verapamil-tab-180mg-container-label-500count.jpg (Verapamil Tab 180mg Container Label 500count)
Label for Verapamil Hydrochloride Extended-Release Tablets, USP 180 mg by Cadila Pharmaceuticals Limited. The label states the dosage form as oral tablets, extended release, with a package size of 500 tablets. It includes storage instructions, manufacturer details in Gujarat, India, and mentions the product meets Dissolution Test 3. The label also notes Rx only status.*
FDA Label Image

Verapamil-tab-240mg-container-label-100count.jpg (Verapamil Tab 240mg Container Label 100count)

Verapamil-tab-240mg-container-label-100count.jpg (Verapamil Tab 240mg Container Label 100count)
Label for Verapamil Hydrochloride Extended-Release Tablets, USP, 240 mg strength. The label states the product contains 100 tablets manufactured by Cadila Pharmaceuticals Limited in Ahmedabad, India. It includes storage instructions, dosage form as extended-release oral tablets, and notes the product is prescription-only with NDC 71209-048-05.*
FDA Label Image

Verapamil-tab-240mg-container-label-500count.jpg (Verapamil Tab 240mg Container Label 500count)

Verapamil-tab-240mg-container-label-500count.jpg (Verapamil Tab 240mg Container Label 500count)
Label for Verapamil Hydrochloride Extended-Release Tablets, USP, 240 mg strength. The label indicates the product contains 500 tablets and is manufactured by Cadila Pharmaceuticals Limited. It includes storage instructions, dosage and use directions, and a barcode. The product is labeled Rx only and designed to meet Dissolution Test 3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.